The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Establishing Asymchem’s first manufacturing footprint in Europe
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Subscribe To Our Newsletter & Stay Updated
